| Date Filed | Type | Description |
| 02/07/2014 |
SC 13D/A
| Cornerstone BioPharma Holdings, Ltd. reports a 0% stake in Cornerstone Therapeutics Inc. |
| 02/04/2014 |
SC 13D/A
| Chiesi Farmaceutici SpA reports a 100% stake in Cornerstone Therapeutics Inc. |
| 02/03/2014 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 02/03/2014 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...|
Docs:
|
"CORNERSTONE THERAPEUTICS INC. STOCKHOLDERS APPROVE MERGER CARY, N.C., February 3, 2014 - Cornerstone Therapeutics Inc. , a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets, today announced that its stockholders have approved, at a special stockholder meeting held today, the previously announced merger agreement, under which Chiesi Farmaceutici S.p.A. will acquire all of the outstanding common shares of Cornerstone for $9.50 per share in cash. Votes “FOR” the adoption of the merger agreement totaled approximately 22,541,184 shares, or 83.73% of Cornerstone's outstanding shares of common stock and entitled to vote thereon. Approximately 4,395,908 shares, or 50.22% of the shares not owned by Chiesi or any of its subsidiaries ..." |
|
| 01/31/2014 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 01/31/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/26/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 12/24/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 12/13/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/27/2013 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/07/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 11/07/2013 |
8-K
| Quarterly results |
| 10/31/2013 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 10/17/2013 |
SC 13E3
| Form SC 13E3 - Going private transaction by certain issuers: |
| 10/04/2013 |
ARS
| Form ARS - Annual Report to Security Holders |
| 10/03/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 09/16/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 09/16/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 08/27/2013 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 08/20/2013 |
8-K
| Other Events |
| 08/06/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 08/06/2013 |
8-K
| Quarterly results |
| 07/26/2013 |
8-K
| Other Events |
| 06/20/2013 |
8-K
| Other Events |
| 05/09/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 05/09/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 05/09/2013 |
8-K
| Quarterly results |
| 04/11/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 03/20/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/14/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 03/14/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/14/2013 |
8-K
| Quarterly results |
| 02/25/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/19/2013 |
SC 13D/A
| Chiesi Farmaceutici SpA reports a 65% stake in Cornerstone Therapeutics Inc. |
|